Skip to main content

Find Clinical Trials

Home
Conditions
Mixed Hyperlipidemia

Clinical trial condition

Mixed Hyperlipidemia

Explore clinical trials studying Mixed Hyperlipidemia. Study availability and eligibility vary by location and protocol.

8 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Mixed Hyperlipidemia trial results

Recruiting

A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia

NCT07695597

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Completed

Efficacy and Safety of SHR-1209 Combined With Lipid-lowering Agents in Patients With Hypercholesterolemia

NCT04885218

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Beijing Anzhen hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)

NCT00941603

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Not specified

View Trial Details

Completed

Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)

NCT00289900

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Not specified

View Trial Details

Completed

Lipid Efficacy Study (0524B-022)(COMPLETED)

NCT00269217

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Not specified

View Trial Details

Completed

A Pilot Study to Evaluate the Lipid Effects of TRIA-662

NCT02008084

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Crowfoot Village Family Practice Calgary, Alberta, Canada

Dr. Senaratne Professional Corporation Edmonton, Alberta, Canada

The Bailey Clinic Red Deer, Alberta, Canada

Manna Research Vancouver Vancouver, British Columbia, Canada

View all 17 locations

View Trial Details

Completed

A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED)

NCT01012219

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Not specified

View Trial Details

Completed

Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care

NCT00345657

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemia, Dyslipidemias, +11 more
Locations: Family Medical Care of Tulsa Tulsa, Oklahoma, United States

View Trial Details